实验方案(Protocols)

3-Chlorobicyclo[1.1.1]pentane-1-carboxylic Acid: Use Protocol

3-chlorobicyclo[1.1.1]pentane-1-carboxylic acid is a strained-ring bifunctional building block combining a reactive C–Cl handle and a carboxylic acid on a rigid bicyclo[1.1.1]pentane (BCP) scaffold, enabling versatile elaboration in medicinal chemistry synthesis workflows.

SKU / Catalog Number
C174546
Molecular Formula
C6H7ClO2
Molecular Weight
146.57 g/mol
Core Scaffold
Bicyclo[1.1.1]pentane (BCP)
Key Functional Groups
Tertiary alkyl chloride; carboxylic acid
Primary Application
Bioisosteric replacement and medicinal chemistry synthesis
Recommended Storage
Cool, dry place; away from light and moisture (verify with SDS)

Overview and Chemical Properties

3-Chlorobicyclo[1.1.1]pentane-1-carboxylic acid (SKU: C174546) belongs to the bicyclo[1.1.1]pentane (BCP) family of strained-ring compounds. The BCP core consists of three fused cyclopropane-like rings sharing a central C–C bond, producing a rigid, three-dimensional scaffold with a C1–C3 interatomic distance comparable to a para-substituted benzene ring. This geometric similarity, combined with improved aqueous solubility and metabolic stability relative to aryl rings, has made BCP derivatives highly attractive as bioisosteric replacements for benzene, tert-butyl, and alkyne groups in drug discovery programs.

The title compound bears two functional handles at the bridgehead positions: a carboxylic acid (–COOH) at C1 and a chloro substituent (–Cl) at C3. The tertiary alkyl chloride at the strained bridgehead position confers distinct reactivity compared to typical secondary or primary alkyl chlorides, and can participate in radical, organometallic, and nucleophilic substitution pathways under appropriate conditions. The carboxylic acid enables standard amide coupling, esterification, and Curtius rearrangement chemistry, making C174546 a versatile bifunctional linchpin for multi-step synthesis.

Safety and Handling

General Precautions: Always consult the Safety Data Sheet (SDS) for C174546 before use. As with all halogenated carboxylic acid derivatives, treat this compound as a potential irritant to skin, eyes, and respiratory tract. Conduct all weighing and handling operations in a well-ventilated fume hood while wearing appropriate personal protective equipment (PPE): chemical-resistant nitrile gloves, safety goggles or face shield, and a laboratory coat.

Storage: Store the compound in a tightly sealed container in a cool, dry location away from direct light and moisture. Segregate from strong bases, oxidising agents, and reactive metals. Confirm specific storage temperature requirements on the product label and SDS, as conditions may differ by lot.

Waste Disposal: Dispose of all waste in accordance with local and institutional regulations governing halogenated organic compounds. Do not pour down the drain. Collect waste in a clearly labelled, solvent-compatible container and arrange for licensed hazardous-waste disposal.

Note: All safety information provided here is general guidance. The SDS for C174546 is the authoritative source and must be reviewed prior to any experimental use.

Step-by-Step Experimental Protocol

The following protocol outlines recommended practices for incorporating 3-chlorobicyclo[1.1.1]pentane-1-carboxylic acid (C174546) into synthetic workflows, with amide coupling as an illustrative example. Adapt reagent ratios and conditions to your specific substrate and scale.

  1. Pre-experiment preparation: Review the SDS and relevant literature. Ensure all glassware is oven-dried. Prepare inert-atmosphere conditions (N2 or Ar) if required by your coupling reagents.
  2. Weighing: Tare a suitable vessel on an analytical balance inside the fume hood. Weigh the required amount of C174546 quickly to minimise moisture exposure. Record the exact mass.
  3. Dissolution: Dissolve C174546 in an appropriate anhydrous polar aprotic solvent (e.g., DMF, DCM, or MeCN) at a concentration compatible with downstream reaction stoichiometry. Confirm complete dissolution by visual inspection or gentle sonication.
  4. Activation (amide coupling example): Add a standard coupling reagent (e.g., HATU, EDC/HOBt, or T3P) and a tertiary amine base (e.g., DIPEA, Et3N) to the solution of C174546. Stir at 0 °C to room temperature for 15–30 minutes to pre-activate the carboxylic acid as an active ester or acylium equivalent.
  5. Substrate addition: Add the amine coupling partner (1.0–1.2 equiv) to the activated mixture. Allow the reaction to proceed at room temperature or as required, monitoring by TLC or LCMS.
  6. Workup: Upon completion, quench the reaction with aqueous buffer appropriate to your system. Separate organic and aqueous layers; wash organic layer with saturated NaHCO3 solution and brine. Dry over anhydrous Na2SO4 or MgSO4, filter, and concentrate under reduced pressure.
  7. Purification: Purify the crude product by flash column chromatography or preparative HPLC as appropriate. Confirm identity and purity by 1H NMR, 13C NMR, and HRMS or LCMS.

Note: Reaction conditions for exploiting the C3-chloro handle (e.g., radical substitution, metal-catalysed cross-coupling) will differ substantially. Consult primary literature for specific conditions applicable to BCP bridgehead functionalisations.

Applications in Medicinal Chemistry and Drug Discovery

The BCP scaffold has emerged as a privileged bioisostere in modern drug discovery. Replacement of a para-substituted benzene or a tert-butyl group with a BCP unit can significantly improve key pharmaceutical properties including aqueous solubility, metabolic stability, reduced lipophilicity (logP), and three-dimensional shape diversity. The 1,3-disubstituted BCP motif mimics the geometry of a 1,4-disubstituted arene while offering an sp3-enriched, non-aromatic framework.

3-Chlorobicyclo[1.1.1]pentane-1-carboxylic acid (C174546) is particularly useful because its two orthogonal functional groups allow sequential elaboration: the carboxylic acid can be coupled to amines, alcohols, or further transformed (e.g., Curtius rearrangement to amine), while the bridgehead chloride may be engaged in radical-mediated C–C bond formation or nucleophilic substitution reactions under forcing or catalytic conditions. This dual reactivity enables the rapid construction of complex BCP-containing pharmacophores from a single, commercially available starting material.

Typical application areas include: fragment-based drug discovery (FBDD) where BCP fragments serve as three-dimensional, soluble cores; lead optimisation campaigns seeking to replace metabolically labile aryl or tert-butyl groups; and synthesis of PROTACs, linker-warhead conjugates, and other modular therapeutic architectures requiring rigid spacers.

Troubleshooting and Tips

Low coupling yields: Ensure the carboxylic acid is fully dissolved prior to activation. Use freshly prepared coupling reagent solutions. If using HATU or similar uronium-based reagents, add base before the coupling partner to avoid racemisation or side reactions. Pre-activation time and temperature can be optimised empirically.

Moisture sensitivity: Although the compound itself is not classified as highly moisture-sensitive, the bridgehead C–Cl bond may hydrolyse slowly under strongly basic aqueous conditions. Minimise exposure to water during reactions and workup when the chloride handle is intended for downstream use.

Solubility issues: BCP carboxylic acids generally show good solubility in polar aprotic solvents (DMF, DMSO, NMP) and moderate solubility in DCM, EtOAc, and THF. Poor solubility in non-polar solvents is expected. Adding a small volume of DMSO as a co-solvent can assist dissolution at higher concentrations.

Characterisation: The rigid BCP framework produces characteristic signals in 1H NMR: the methylene bridge protons (–CH2–) typically appear as a singlet or AB quartet around δ 2.0–2.5 ppm. Confirm the chloro-BCP scaffold by 13C NMR (quaternary bridgehead carbons) and high-resolution mass spectrometry (HRMS). Isotope pattern analysis (35Cl/37Cl, ~3:1) in mass spectra confirms chlorine incorporation.

Frequently asked questions

What is the primary use of 3-chlorobicyclo[1.1.1]pentane-1-carboxylic acid in research?

It is primarily used as a bifunctional building block in medicinal chemistry and drug discovery. The carboxylic acid group enables amide coupling, esterification, and related transformations, while the bridgehead chloride provides a handle for further C–C or C–heteroatom bond-forming reactions. Together, these features allow rapid construction of BCP-containing pharmacophores that serve as bioisosteric replacements for aryl and tert-butyl groups.

How should C174546 be stored to maintain its integrity?

The compound should be stored in a tightly sealed container in a cool, dry place away from light, moisture, strong bases, and oxidising agents. Specific storage temperature and conditions are detailed in the product SDS and label, which should be consulted as the authoritative reference. Avoiding repeated freeze-thaw cycles and minimising headspace in the storage container are also recommended best practices.

Can the bridgehead C–Cl bond of C174546 undergo cross-coupling reactions?

Bridgehead C–Cl bonds in BCP systems exhibit unique reactivity due to ring strain and the tertiary sp3 carbon nature of the position. Radical-mediated substitution and certain metal-catalysed processes have been reported for analogous BCP halides in the literature; however, classical palladium-catalysed cross-coupling conditions effective for aryl or vinyl chlorides may not apply directly. Researchers should consult primary literature on BCP bridgehead functionalisation and validate conditions empirically for their specific substrate combinations.

What solvents are recommended for dissolving C174546?

Polar aprotic solvents such as DMF, DMSO, NMP, and acetonitrile are recommended for achieving good solubility. Moderate solubility is expected in DCM, EtOAc, and THF. Non-polar solvents such as hexane or toluene are generally poor choices. If solubility remains challenging at the desired concentration, adding a small volume of DMSO as a co-solvent may help.

How can I confirm the identity and purity of C174546 after receipt?

Identity can be confirmed by 1H NMR (characteristic BCP methylene bridge protons at approximately δ 2.0–2.5 ppm) and 13C NMR (quaternary bridgehead carbons). High-resolution mass spectrometry (HRMS) with isotope pattern analysis (35Cl/37Cl ~3:1 ratio) confirms molecular formula and chlorine incorporation. Purity can be assessed by HPLC with UV detection or quantitative NMR (qNMR). The Certificate of Analysis (CoA) provided by Aladdin Scientific should be reviewed for lot-specific purity data.

References

  1. Stepan, A. F. et al. Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active gamma-secretase inhibitor. Journal of Medicinal Chemistry, 2012. doi:10.1021/jm300123z
  2. Measom, N. D. et al. Investigation of a bicyclo[1.1.1]pentane as a phenyl bioisostere in a drug discovery programme. ACS Medicinal Chemistry Letters, 2017. doi:10.1021/acsmedchemlett.7b00105
  3. Gianatassio, R. et al. Strain-release amination. Science, 2016. doi:10.1126/science.aag2465
  4. Kanazawa, J.; Uchiyama, M. Recent advances in the synthetic chemistry of bicyclo[1.1.1]pentane. Synlett, 2019.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《3-Chlorobicyclo[1.1.1]pentane-1-carboxylic Acid: Use Protocol》. 阿拉丁知识库,更新于 2026年10月3日。 https://www.aladdin-e.com/zh_cn/faqs/3-chlorobicyclo-1-1-1-pentane-1-carboxylic-acid-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 3 人觉得有帮助